Viewing Study NCT01076556


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2025-12-31 @ 10:09 PM
Study NCT ID: NCT01076556
Status: TERMINATED
Last Update Posted: 2015-11-11
First Post: 2010-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module